A detailed history of Napatree Capital LLC transactions in Regenxbio Inc. stock. As of the latest transaction made, Napatree Capital LLC holds 35,125 shares of RGNX stock, worth $267,652. This represents 0.26% of its overall portfolio holdings.

Number of Shares
35,125
Previous 49,764 29.42%
Holding current value
$267,652
Previous $582 Million 36.72%
% of portfolio
0.26%
Previous 0.47%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$10.49 - $14.39 $153,563 - $210,655
-14,639 Reduced 29.42%
35,125 $368 Million
Q2 2024

Aug 13, 2024

BUY
$11.51 - $21.53 $48,065 - $89,909
4,176 Added 9.16%
49,764 $582 Million
Q1 2024

May 13, 2024

BUY
$12.17 - $24.61 $66,569 - $134,616
5,470 Added 13.63%
45,588 $700 Million
Q4 2023

Mar 26, 2024

BUY
$12.89 - $20.82 $517,121 - $835,256
40,118 New
40,118 $720 Million

Others Institutions Holding RGNX

About REGENXBIO Inc.


  • Ticker RGNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,230,000
  • Market Cap $329M
  • Description
  • REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...
More about RGNX
Track This Portfolio

Track Napatree Capital LLC Portfolio

Follow Napatree Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Napatree Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Napatree Capital LLC with notifications on news.